More importantly, a recent study in humans with different stages of NAFLD revealed a linear correlation between steatosis, inflammation and global NAS scores with hepatic Cd8+ T cells [14], also in agreement with our data. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.